| 1 | CasPEDIA Database: a functional classification system for class 2 CRISPR-Cas enzymes | 16.2 | 14 | Citations (PDF) |
| 2 | In vivo human T cell engineering with enveloped delivery vehicles | 18.1 | 45 | Citations (PDF) |
| 3 | Engineering self-deliverable ribonucleoproteins for genome editing in the brain | 14.1 | 14 | Citations (PDF) |
| 4 | Targeted nonviral delivery of genome editors in vivo | 7.7 | 13 | Citations (PDF) |
| 5 | An essential and highly selective protein import pathway encoded by nucleus-forming phage | 7.7 | 5 | Citations (PDF) |
| 6 | Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9Cell, 2024, 187, 3249-3261.e14 | 35.1 | 14 | Citations (PDF) |
| 7 | Structure-guided discovery of ancestral CRISPR-Cas13 ribonucleases | 38.2 | 3 | Citations (PDF) |
| 8 | Birth of protein folds and functions in the virome | 40.1 | 7 | Citations (PDF) |
| 9 | Oligomeric State and Drug Binding of the SARS-CoV-2 Envelope Protein Are Sensitive to the Ectodomain | 15.7 | 4 | Citations (PDF) |
| 10 | Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein | 18.1 | 4 | Citations (PDF) |
| 11 | Genome editing in plants using the compact editor CasΦ | 7.7 | 25 | Citations (PDF) |
| 12 | Precise transcript targeting by CRISPR-Csm complexes | 18.1 | 39 | Citations (PDF) |
| 13 | CRISPR technology: A decade of genome editing is only the beginning | 38.2 | 449 | Citations (PDF) |
| 14 | To TnpB or not TnpB? Cas12 is the answer | 7.3 | 1 | Citations (PDF) |
| 15 | Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6 | 14.1 | 26 | Citations (PDF) |
| 16 | Genome expansion by a CRISPR trimmer-integrase | 40.1 | 9 | Citations (PDF) |
| 17 | Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs | 10.5 | 15 | Citations (PDF) |
| 18 | Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsCell, 2023, 186, 4567-4582.e20 | 35.1 | 60 | Citations (PDF) |
| 19 | Assembly of SARS-CoV-2 ribonucleosomes by truncated N∗ variant of the nucleocapsid protein | 2.3 | 11 | Citations (PDF) |
| 20 | Infant microbiome cultivation and metagenomic analysis reveal Bifidobacterium 2’-fucosyllactose utilization can be facilitated by coexisting species | 14.1 | 9 | Citations (PDF) |
| 21 | Eukaryotic RNA-guided endonucleases evolved from a unique clade of bacterial enzymes | 16.2 | 13 | Citations (PDF) |
| 22 | Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity | 14.2 | 38 | Citations (PDF) |
| 23 | Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variantsCell, 2022, 185, 1539-1548.e5 | 35.1 | 117 | Citations (PDF) |
| 24 | A functional map of HIV-host interactions in primary human T cells | 14.1 | 28 | Citations (PDF) |
| 25 | CRISPR–Cas9 bends and twists DNA to read its sequence | 6.4 | 41 | Citations (PDF) |
| 26 | Crystal structure of an RNA/DNA strand exchange junction | 2.5 | 3 | Citations (PDF) |
| 27 | Structural biology of CRISPR–Cas immunity and genome editing enzymes | 27.5 | 103 | Citations (PDF) |
| 28 | Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination | 40.1 | 144 | Citations (PDF) |
| 29 | A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression | 14.2 | 34 | Citations (PDF) |
| 30 | Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles | 7.7 | 114 | Citations (PDF) |
| 31 | Borgs are giant genetic elements with potential to expand metabolic capacity | 40.1 | 31 | Citations (PDF) |
| 32 | Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing | 12.8 | 50 | Citations (PDF) |
| 33 | Diverse virus-encoded CRISPR-Cas systems include streamlined genome editorsCell, 2022, 185, 4574-4586.e16 | 35.1 | 71 | Citations (PDF) |
| 34 | Decorating chromatin for enhanced genome editing using CRISPR-Cas9 | 7.7 | 20 | Citations (PDF) |
| 35 | Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopyCell, 2021, 184, 323-333.e9 | 35.1 | 654 | Citations (PDF) |
| 36 | Genome-resolved metagenomics reveals site-specific diversity of episymbiotic CPR bacteria and DPANN archaea in groundwater ecosystems | 12.8 | 122 | Citations (PDF) |
| 37 | Human Molecular Genetics and Genomics — Important Advances and Exciting Possibilities | 25.5 | 39 | Citations (PDF) |
| 38 | Quantification of Cas9 binding and cleavage across diverse guide sequences maps landscapes of target engagement | 11.3 | 28 | Citations (PDF) |
| 39 | Cancer-specific loss of
<i>TERT</i>
activation sensitizes glioblastoma to DNA damage | 7.7 | 33 | Citations (PDF) |
| 40 | The NIH Somatic Cell Genome Editing program | 40.1 | 82 | Citations (PDF) |
| 41 | Structural coordination between active sites of a CRISPR reverse transcriptase-integrase complex | 14.1 | 13 | Citations (PDF) |
| 42 | Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus | 2.5 | 15 | Citations (PDF) |
| 43 | DNA interference states of the hypercompact CRISPR–CasΦ effector | 6.4 | 56 | Citations (PDF) |
| 44 | Accelerated RNA detection using tandem CRISPR nucleases | 7.3 | 157 | Citations (PDF) |
| 45 | Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples | 2.5 | 14 | Citations (PDF) |
| 46 | Synthesis of Multi-Protein Complexes through Charge-Directed Sequential Activation of Tyrosine Residues | 15.7 | 20 | Citations (PDF) |
| 47 | Kinetic analysis of Cas12a and Cas13a RNA-Guided nucleases for development of improved CRISPR-Based diagnostics | 3.8 | 73 | Citations (PDF) |
| 48 | Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules | 14.1 | 28 | Citations (PDF) |
| 49 | LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples | 2.5 | 6 | Citations (PDF) |
| 50 | Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment | 2.4 | 24 | Citations (PDF) |
| 51 | Species- and site-specific genome editing in complex bacterial communities | 12.8 | 148 | Citations (PDF) |
| 52 | Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery | 9.3 | 75 | Citations (PDF) |
| 53 | Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation | 2.3 | 68 | Citations (PDF) |
| 54 | Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine–Cysteine Bond Formation | 9.6 | 67 | Citations (PDF) |
| 55 | Blueprint for a pop-up SARS-CoV-2 testing lab | 18.1 | 34 | Citations (PDF) |
| 56 | Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity | 18.1 | 563 | Citations (PDF) |
| 57 | Potent CRISPR-Cas9 inhibitors from<i>Staphylococcus</i>genomes | 7.7 | 48 | Citations (PDF) |
| 58 | Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling | 7.7 | 61 | Citations (PDF) |
| 59 | A scoutRNA Is Required for Some Type V CRISPR-Cas Systems | 14.2 | 57 | Citations (PDF) |
| 60 | Clades of huge phages from across Earth’s ecosystems | 40.1 | 303 | Citations (PDF) |
| 61 | The promise and challenge of therapeutic genome editing | 40.1 | 667 | Citations (PDF) |
| 62 | Machine learning predicts new anti-CRISPR proteins | 16.2 | 71 | Citations (PDF) |
| 63 | Controlling and enhancing CRISPR systems | 7.3 | 123 | Citations (PDF) |
| 64 | Massively parallel kinetic profiling of natural and engineered CRISPR nucleases | 18.1 | 82 | Citations (PDF) |
| 65 | Attachment of a 32P-phosphate to the 3′ Terminus of a DNA Oligonucleotide | 0.8 | 1 | Citations (PDF) |
| 66 | Author response: CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks 2020, , | | 0 | Citations (PDF) |
| 67 | Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble | 14.1 | 33 | Citations (PDF) |
| 68 | CRISPR's unwanted anniversary | 38.2 | 11 | Citations (PDF) |
| 69 | A Functional Mini-Integrase in a Two-Protein Type V-C CRISPR System | 14.2 | 19 | Citations (PDF) |
| 70 | Spacer Acquisition Rates Determine the Immunological Diversity of the Type II CRISPR-Cas Immune Response | 15.2 | 16 | Citations (PDF) |
| 71 | Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2 | 14.1 | 50 | Citations (PDF) |
| 72 | Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs | 14.1 | 134 | Citations (PDF) |
| 73 | Deciphering Off-Target Effects in CRISPR-Cas9 through Accelerated Molecular Dynamics | 9.6 | 92 | Citations (PDF) |
| 74 | Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules | 7.7 | 124 | Citations (PDF) |
| 75 | Broad-spectrum enzymatic inhibition of CRISPR-Cas12a | 6.4 | 87 | Citations (PDF) |
| 76 | The NAI Fellow Profile: An Interview with Dr. Jennifer Doudna | 0.4 | 0 | Citations (PDF) |
| 77 | Reply to Nathamgari et al.: Nanopore electroporation for intracellular delivery of biological macromolecules | 7.7 | 3 | Citations (PDF) |
| 78 | Temperature-Responsive Competitive Inhibition of CRISPR-Cas9 | 14.2 | 56 | Citations (PDF) |
| 79 | CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome ModificationCell, 2019, 176, 254-267.e16 | 35.1 | 75 | Citations (PDF) |
| 80 | CasX enzymes comprise a distinct family of RNA-guided genome editors | 40.1 | 327 | Citations (PDF) |
| 81 | CRISPR System: From Adaptive Immunity to Genome Editing 2019, , 81-116 | | 0 | Citations (PDF) |
| 82 | Author response: Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a 2019, , | | 1 | Citations (PDF) |
| 83 | Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing | 15.7 | 130 | Citations (PDF) |
| 84 | Programmable RNA recognition using a CRISPR-associated Argonaute | 7.7 | 37 | Citations (PDF) |
| 85 | Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies | 15.0 | 66 | Citations (PDF) |
| 86 | Genome im Fokus: Entwicklung und Anwendungen von CRISPR‐Cas9‐Bildgebungstechnologien | 1.5 | 5 | Citations (PDF) |
| 87 | A Unified Resource for Tracking Anti-CRISPR Names | 3.7 | 87 | Citations (PDF) |
| 88 | Key role of the REC lobe during CRISPR–Cas9 activation by ‘sensing’, ‘regulating’, and ‘locking’ the catalytic HNH domain | 3.8 | 79 | Citations (PDF) |
| 89 | Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner | 33.4 | 98 | Citations (PDF) |
| 90 | CRISPR-Cas guides the future of genetic engineering | 38.2 | 1,018 | Citations (PDF) |
| 91 | The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders | 35.1 | 88 | Citations (PDF) |
| 92 | RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a | 6.4 | 94 | Citations (PDF) |
| 93 | Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection | 14.0 | 96 | Citations (PDF) |
| 94 | Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes | 18.1 | 265 | Citations (PDF) |
| 95 | RNA-based recognition and targeting: sowing the seeds of specificity | 31.4 | 152 | Citations (PDF) |
| 96 | Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery | 16.2 | 62 | Citations (PDF) |
| 97 | High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding | 7.7 | 132 | Citations (PDF) |
| 98 | RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes | 14.2 | 208 | Citations (PDF) |
| 99 | CRISPR–Cas9 Structures and Mechanisms | 13.3 | 1,357 | Citations (PDF) |
| 100 | Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response | 14.2 | 42 | Citations (PDF) |
| 101 | Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair | 18.8 | 592 | Citations (PDF) |
| 102 | The chemistry of Cas9 and its CRISPR colleagues | 23.4 | 106 | Citations (PDF) |
| 103 | CRISPR System: From Adaptive Immunity to Genome Editing | 1.8 | 0 | Citations (PDF) |
| 104 | A Broad-Spectrum Inhibitor of CRISPR-Cas9Cell, 2017, 170, 1224-1233.e15 | 35.1 | 185 | Citations (PDF) |
| 105 | Enhanced proofreading governs CRISPR–Cas9 targeting accuracy | 40.1 | 848 | Citations (PDF) |
| 106 | Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme | 6.4 | 114 | Citations (PDF) |
| 107 | Disabling Cas9 by an anti-CRISPR DNA mimic | 11.3 | 263 | Citations (PDF) |
| 108 | A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9 | 11.3 | 202 | Citations (PDF) |
| 109 | Structures of the CRISPR genome integration complex | 38.2 | 104 | Citations (PDF) |
| 110 | CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing | 14.1 | 206 | Citations (PDF) |
| 111 | Widespread Translational Remodeling during Human Neuronal Differentiation | 6.4 | 93 | Citations (PDF) |
| 112 | A thermostable Cas9 with increased lifetime in human plasma | 14.1 | 132 | Citations (PDF) |
| 113 | Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain | 5.2 | 99 | Citations (PDF) |
| 114 | RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System | 2.5 | 65 | Citations (PDF) |
| 115 | DNA recognition by an RNA-guided bacterial Argonaute | 2.5 | 45 | Citations (PDF) |
| 116 | Author response: RNA-dependent RNA targeting by CRISPR-Cas9 2017, , | | 0 | Citations (PDF) |
| 117 | CRISPR Immunological Memory Requires a Host Factor for Specificity | 14.2 | 126 | Citations (PDF) |
| 118 | A bacterial Argonaute with noncanonical guide RNA specificity | 7.7 | 107 | Citations (PDF) |
| 119 | Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch | 18.1 | 153 | Citations (PDF) |
| 120 | Protecting genome integrity during CRISPR immune adaptation | 6.4 | 58 | Citations (PDF) |
| 121 | Applications of CRISPR technologies in research and beyond | 18.1 | 701 | Citations (PDF) |
| 122 | Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection | 40.1 | 846 | Citations (PDF) |
| 123 | DNA Targeting by a Minimal CRISPR RNA-Guided Cascade | 14.2 | 63 | Citations (PDF) |
| 124 | Foreign DNA capture during CRISPR–Cas adaptive immunity | 40.1 | 1 | Citations (PDF) |
| 125 | ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing | 14.5 | 158 | Citations (PDF) |
| 126 | A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells | 6.4 | 136 | Citations (PDF) |
| 127 | Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9 | 14.1 | 197 | Citations (PDF) |
| 128 | Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering | 35.1 | 812 | Citations (PDF) |
| 129 | Programmable RNA Tracking in Live Cells with CRISPR/Cas9 | 35.1 | 417 | Citations (PDF) |
| 130 | Analog sensitive chemical inhibition of the <scp>DEAD</scp>‐box protein <scp>DDX</scp>3 | 5.9 | 11 | Citations (PDF) |
| 131 | Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering | 3.9 | 76 | Citations (PDF) |
| 132 | Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3 | 2.3 | 65 | Citations (PDF) |
| 133 | New CRISPR–Cas systems from uncultivated microbes | 40.1 | 446 | Citations (PDF) |
| 134 | Cornerstones of CRISPR–Cas in drug discovery and therapy | 39.3 | 352 | Citations (PDF) |
| 135 | Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress | 1.7 | 63 | Citations (PDF) |
| 136 | Author response: Reconstitution of selective HIV-1 RNA packaging in vitro by membrane-bound Gag assemblies 2016, , | | 0 | Citations (PDF) |
| 137 | Author response: Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex 2016, , | | 0 | Citations (PDF) |
| 138 | Genome editing: the end of the beginning | 8.4 | 15 | Citations (PDF) |
| 139 | Genome-editing revolution: My whirlwind year with CRISPR | 40.1 | 31 | Citations (PDF) |
| 140 | Expanding the Biologist’s Toolkit with CRISPR-Cas9 | 14.2 | 325 | Citations (PDF) |
| 141 | Dicer-TRBP Complex Formation Ensures Accurate Mammalian MicroRNA Biogenesis | 14.2 | 205 | Citations (PDF) |
| 142 | Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity | 40.1 | 267 | Citations (PDF) |
| 143 | Rational design of a split-Cas9 enzyme complex | 7.7 | 229 | Citations (PDF) |
| 144 | Genomic Engineering and the Future of Medicine | 13.7 | 22 | Citations (PDF) |
| 145 | The structural biology of CRISPR-Cas systems | 7.1 | 135 | Citations (PDF) |
| 146 | Generation of knock-in primary human T cells using Cas9 ribonucleoproteins | 7.7 | 553 | Citations (PDF) |
| 147 | CRISPR germline engineering—the community speaks | 18.1 | 104 | Citations (PDF) |
| 148 | Conformational control of DNA target cleavage by CRISPR–Cas9 | 40.1 | 460 | Citations (PDF) |
| 149 | Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes | 14.2 | 84 | Citations (PDF) |
| 150 | Foreign DNA capture during CRISPR–Cas adaptive immunity | 40.1 | 152 | Citations (PDF) |
| 151 | Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System | 35.1 | 149 | Citations (PDF) |
| 152 | Ancient Origin of cGAS-STING Reveals Mechanism of Universal 2′,3′ cGAMP Signaling | 14.2 | 199 | Citations (PDF) |
| 153 | Cutting it close: CRISPR-associated endoribonuclease structure and function | 8.1 | 109 | Citations (PDF) |
| 154 | Author response: Tunable protein synthesis by transcript isoforms in human cells 2015, , | | 0 | Citations (PDF) |
| 155 | Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases | 16.2 | 64 | Citations (PDF) |
| 156 | The new frontier of genome engineering with CRISPR-Cas9 | 38.2 | 4,829 | Citations (PDF) |
| 157 | Preface | 1.0 | 24 | Citations (PDF) |
| 158 | New tools provide a second look at HDV ribozyme structure, dynamics and cleavage | 16.2 | 31 | Citations (PDF) |
| 159 | Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation | 38.2 | 907 | Citations (PDF) |
| 160 | CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference | 7.7 | 173 | Citations (PDF) |
| 161 | Insights into RNA structure and function from genome-wide studies | 19.1 | 337 | Citations (PDF) |
| 162 | DNA interrogation by the CRISPR RNA-guided endonuclease Cas9 | 40.1 | 1,394 | Citations (PDF) |
| 163 | RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus | 14.2 | 242 | Citations (PDF) |
| 164 | Evolutionarily Conserved Roles of the Dicer Helicase Domain in Regulating RNA Interference Processing | 2.3 | 18 | Citations (PDF) |
| 165 | Structure-Guided Reprogramming of Human cGAS Dinucleotide Linkage SpecificityCell, 2014, 158, 1011-1021 | 35.1 | 101 | Citations (PDF) |
| 166 | Programmable RNA recognition and cleavage by CRISPR/Cas9 | 40.1 | 525 | Citations (PDF) |
| 167 | Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity | 6.4 | 348 | Citations (PDF) |
| 168 | Author response: Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery 2014, , | | 11 | Citations (PDF) |
| 169 | Author response: RNA-guided assembly of Rev-RRE nuclear export complexes 2014, , | | 0 | Citations (PDF) |
| 170 | High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity | 18.1 | 1,188 | Citations (PDF) |
| 171 | CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes | 35.1 | 2,760 | Citations (PDF) |
| 172 | Structure and Activity of the RNA-Targeting Type III-B CRISPR-Cas Complex of Thermus thermophilus | 14.2 | 188 | Citations (PDF) |
| 173 | Rewriting a genome | 40.1 | 173 | Citations (PDF) |
| 174 | Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013, 152, 1173-1183 | 35.1 | 3,748 | Citations (PDF) |
| 175 | Substrate-specific structural rearrangements of human Dicer | 6.4 | 80 | Citations (PDF) |
| 176 | Molecular Mechanisms of RNA Interference | 13.3 | 818 | Citations (PDF) |
| 177 | Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing | 16.2 | 162 | Citations (PDF) |
| 178 | Multiple sensors ensure guide strand selection in human RNAi pathways | 3.9 | 107 | Citations (PDF) |
| 179 | ATP-independent diffusion of double-stranded RNA binding proteins | 7.7 | 57 | Citations (PDF) |
| 180 | Hepatitis C virus 3′UTR regulates viral translation through direct interactions with the host translation machinery | 16.2 | 57 | Citations (PDF) |
| 181 | RNA–protein analysis using a conditional CRISPR nuclease | 7.7 | 68 | Citations (PDF) |
| 182 | Defending the Genome: Regulatory RNA in Humans and Bacteria | 0.7 | 0 | Citations (PDF) |
| 183 | Csy4 relies on an unusual catalytic dyad to position and cleave CRISPR RNA | 7.4 | 80 | Citations (PDF) |
| 184 | Native Tandem and Ion Mobility Mass Spectrometry Highlight Structural and Modular Similarities in Clustered-Regularly-Interspaced Shot-Palindromic-Repeats (CRISPR)-associated Protein Complexes From Escherichia coli and Pseudomonas aeruginosa | 4.8 | 69 | Citations (PDF) |
| 185 | Mechanism of substrate selection by a highly specific CRISPR endoribonuclease | 3.9 | 121 | Citations (PDF) |
| 186 | TRBP alters human precursor microRNA processing in vitro | 3.9 | 110 | Citations (PDF) |
| 187 | RNA processing enables predictable programming of gene expression | 18.1 | 164 | Citations (PDF) |
| 188 | Coordinated Activities of Human Dicer Domains in Regulatory RNA Processing | 4.2 | 62 | Citations (PDF) |
| 189 | Mechanism of Foreign DNA Selection in a Bacterial Adaptive Immune System | 14.2 | 201 | Citations (PDF) |
| 190 | RNA-guided genetic silencing systems in bacteria and archaea | 40.1 | 1,494 | Citations (PDF) |
| 191 | A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity | 38.2 | 12,027 | Citations (PDF) |
| 192 | Preliminary in vitro functional analysis of the DEAD‐box protein DDX3 | 0.7 | 0 | Citations (PDF) |
| 193 | Multiplexed RNA structure characterization with selective 2′-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq) | 7.7 | 293 | Citations (PDF) |
| 194 | Structures of the RNA-guided surveillance complex from a bacterial immune system | 40.1 | 318 | Citations (PDF) |
| 195 | RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions | 7.7 | 359 | Citations (PDF) |
| 196 | Structural basis for CRISPR RNA-guided DNA recognition by Cascade | 6.4 | 458 | Citations (PDF) |
| 197 | An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3 | 6.4 | 147 | Citations (PDF) |
| 198 | Crystal Structure of the HCV IRES Central Domain Reveals Strategy for Start-Codon Positioning | 3.9 | 98 | Citations (PDF) |
| 199 | Modeling and automation of sequencing-based characterization of RNA structure | 7.7 | 91 | Citations (PDF) |
| 200 | Structural insights into RNA interference | 7.1 | 67 | Citations (PDF) |
| 201 | Functional Overlap between eIF4G Isoforms in Saccharomyces cerevisiae | 2.5 | 48 | Citations (PDF) |
| 202 | Substrate-Specific Kinetics of Dicer-Catalyzed RNA Processing | 4.2 | 122 | Citations (PDF) |
| 203 | Structural Basis for DNase Activity of a Conserved Protein Implicated in CRISPR-Mediated Genome Defense | 3.9 | 202 | Citations (PDF) |
| 204 | Structural insights into RNA processing by the human RISC-loading complex | 6.4 | 199 | Citations (PDF) |
| 205 | Autoinhibition of Human Dicer by Its Internal Helicase Domain | 4.2 | 178 | Citations (PDF) |
| 206 | <i>In vitro</i>
reconstitution of the human RISC-loading complex | 7.7 | 333 | Citations (PDF) |
| 207 | A three-dimensional view of the molecular machinery of RNA interference | 40.1 | 578 | Citations (PDF) |
| 208 | Getting the message: Mechanisms of protein synthesis initiation | 0.7 | 0 | Citations (PDF) |
| 209 | Ribonuclease revisited: structural insights into ribonuclease III family enzymes | 7.1 | 188 | Citations (PDF) |
| 210 | GTP-dependent Formation of a Ribonucleoprotein Subcomplex Required for Ribosome Biogenesis | 4.2 | 34 | Citations (PDF) |
| 211 | Structural Characterization and Identification of Post‐Translational Modifications of Human Eukaryotic Initiation Factor 3 (eIF3) by FTICR Mass Spectrometry | 0.7 | 0 | Citations (PDF) |
| 212 | Structural Basis for RNA Processing by Dicer | 0.7 | 0 | Citations (PDF) |
| 213 | Ribozyme catalysis: not different, just worse | 6.4 | 137 | Citations (PDF) |
| 214 | Chemical biology at the crossroads of molecular structure and mechanism | 7.3 | 13 | Citations (PDF) |
| 215 | Protein–nucleic acid interactions: unlocking mysteries old and new | 7.1 | 1 | Citations (PDF) |
| 216 | An Essential GTPase Promotes Assembly of Preribosomal RNA Processing Complexes | 14.2 | 65 | Citations (PDF) |
| 217 | A conformational switch controls hepatitis delta virus ribozyme catalysis | 40.1 | 251 | Citations (PDF) |
| 218 | Structural Insights Into the Signal Recognition Particle | 18.3 | 111 | Citations (PDF) |
| 219 | Protein–nucleic acid interactions | 7.1 | 7 | Citations (PDF) |
| 220 | Structural Insights into Group II Intron Catalysis and Branch-Site Selection | 38.2 | 94 | Citations (PDF) |
| 221 | Structure and Function of the Eukaryotic Ribosome | 35.1 | 111 | Citations (PDF) |
| 222 | The chemical repertoire of natural ribozymes | 40.1 | 588 | Citations (PDF) |
| 223 | Direct pKaMeasurement of the Active-Site Cytosine in a Genomic Hepatitis Delta Virus Ribozyme | 15.7 | 88 | Citations (PDF) |
| 224 | Erratum | 3.9 | 3 | Citations (PDF) |
| 225 | The stem-loop binding protein forms a highly stable and specific complex with the 3′ stem-loop of histone mRNAs | 3.9 | 64 | Citations (PDF) |
| 226 | Mechanism of ribosome recruitment by hepatitis C IRES RNA | 3.9 | 317 | Citations (PDF) |
| 227 | Title is missing! | 8.9 | 213 | Citations (PDF) |
| 228 | Crystal Structure of the Ribonucleoprotein Core of the Signal Recognition Particle | 38.2 | 340 | Citations (PDF) |
| 229 | Ribozyme Structures and Mechanisms | 18.3 | 155 | Citations (PDF) |
| 230 | The P5abc Peripheral Element Facilitates Preorganization of the Tetrahymena Group I Ribozyme for Catalysis | 2.9 | 62 | Citations (PDF) |
| 231 | A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes | 3.9 | 80 | Citations (PDF) |
| 232 | Tertiary Motifs in RNA Structure and Folding | 15.0 | 359 | Citations (PDF) |
| 233 | Assembly of an Exceptionally Stable RNA Tertiary Interface in a Group I Ribozyme | 2.9 | 60 | Citations (PDF) |
| 234 | RNA FOLDS: Insights from Recent Crystal Structures | 20.7 | 83 | Citations (PDF) |
| 235 | Crystal structure of a hepatitis delta virus ribozyme | 40.1 | 679 | Citations (PDF) |
| 236 | The P4−P6 Domain Directs Higher Order Folding of theTetrahymenaRibozyme Core† | 2.9 | 70 | Citations (PDF) |
| 237 | A magnesium ion core at the heart of a ribozyme domain | 8.9 | 258 | Citations (PDF) |
| 238 | A molecular contortionist | 40.1 | 7 | Citations (PDF) |
| 239 | Metal-binding sites in the major groove of a large ribozyme domain | 3.9 | 229 | Citations (PDF) |
| 240 | Use of Cis- and Trans-Ribozymes to Remove 5' and 3' Heterogeneities From Milligrams of In Vitro Transcribed RNA | 16.2 | 135 | Citations (PDF) |
| 241 | RNA-programmed genome editing in human cells | 1.6 | 1,665 | Citations (PDF) |
| 242 | Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery | 1.6 | 874 | Citations (PDF) |
| 243 | RNA-guided assembly of Rev-RRE nuclear export complexes | 1.6 | 71 | Citations (PDF) |
| 244 | Nucleosome breathing and remodeling constrain CRISPR-Cas9 function | 1.6 | 154 | Citations (PDF) |
| 245 | Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex | 1.6 | 41 | Citations (PDF) |
| 246 | RNA-dependent RNA targeting by CRISPR-Cas9 | 1.6 | 144 | Citations (PDF) |
| 247 | Tunable protein synthesis by transcript isoforms in human cells | 1.6 | 197 | Citations (PDF) |
| 248 | Reconstitution of selective HIV-1 RNA packaging in vitro by membrane-bound Gag assemblies | 1.6 | 34 | Citations (PDF) |
| 249 | Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a | 1.6 | 40 | Citations (PDF) |
| 250 | CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks | 1.6 | 68 | Citations (PDF) |
